-
- N. Sudarsan
- Howard Hughes Medical Institute, Yale University, New Haven, CT 06520, USA.
-
- E. R. Lee
- Howard Hughes Medical Institute, Yale University, New Haven, CT 06520, USA.
-
- Z. Weinberg
- Howard Hughes Medical Institute, Yale University, New Haven, CT 06520, USA.
-
- R. H. Moy
- Howard Hughes Medical Institute, Yale University, New Haven, CT 06520, USA.
-
- J. N. Kim
- Howard Hughes Medical Institute, Yale University, New Haven, CT 06520, USA.
-
- K. H. Link
- Howard Hughes Medical Institute, Yale University, New Haven, CT 06520, USA.
-
- R. R. Breaker
- Howard Hughes Medical Institute, Yale University, New Haven, CT 06520, USA.
抄録
<jats:p>Cyclic di-guanosine monophosphate (di-GMP) is a circular RNA dinucleotide that functions as a second messenger in diverse species of bacteria to trigger wide-ranging physiological changes, including cell differentiation, conversion between motile and biofilm lifestyles, and virulence gene expression. However, the mechanisms by which cyclic di-GMP regulates gene expression have remained a mystery. We found that cyclic di-GMP in many bacterial species is sensed by a riboswitch class in messenger RNA that controls the expression of genes involved in numerous fundamental cellular processes. A variety of cyclic di-GMP regulons are revealed, including some riboswitches associated with virulence gene expression, pilus formation, and flagellum biosynthesis. In addition, sequences matching the consensus for cyclic di-GMP riboswitches are present in the genome of a bacteriophage.</jats:p>
収録刊行物
-
- Science
-
Science 321 (5887), 411-413, 2008-07-18
American Association for the Advancement of Science (AAAS)